This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003; 361(9358): 681-689.1260618510.1016/S0140-6736(03)12567-6RatjenFDoringGCystic fibrosisLancet20033619358681689Search in Google Scholar
O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009; 373(9678): 1891-1904.1940316410.1016/S0140-6736(09)60327-5O'SullivanBPFreedmanSDCystic fibrosisLancet2009373967818911904Search in Google Scholar
Cutting GR. Cystic fibrosis genetics: From molecular understanding to clinical application. Nat Rev Genet. 2015; 16(1): 45-56.10.1038/nrg384925404111CuttingGRCystic fibrosis genetics: From molecular understanding to clinical applicationNat Rev Genet20151614556Open DOISearch in Google Scholar
Castellani C, Cuppens H, Macek Μ Jr, Cassiman JJ, Kerem E, Durie P, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros. 2008; 7(3): 179-196.1845657810.1016/j.jcf.2008.03.009CastellaniCCuppensHMacekΜ JrCassimanJJKeremEDuriePet alConsensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceJ Cyst Fibros200873179196Search in Google Scholar
Dequeker Ε, Stuhrmann Μ, Morris MA, Casals Τ, Castellani C, Claustres M, et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations. Eur J Hum Genet. 2009; 17(1): 51-65.1868555810.1038/ejhg.2008.136DequekerΕStuhrmannΜMorrisMACasalsΤCastellaniCClaustresMet alBest practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendationsEur J Hum Genet20091715165Search in Google Scholar
Viviani L, Zolin A, Mehta A, Olesen HV. The European Cystic Fibrosis Society Patient Registry: Valuable lessons learned on how to sustain a disease registry. Orphanet J Rare Dis. 2014; 9(1): 81-94.2490805510.1186/1750-1172-9-81VivianiLZolinAMehtaAOlesenHVThe European Cystic Fibrosis Society Patient Registry: Valuable lessons learned on how to sustain a disease registryOrphanet J Rare Dis2014918194Search in Google Scholar
Maiuri L, Raia V, Kroemer G. Strategies for the etiological therapy of cystic fibrosis. Cell Death Differ. 2017; 24(11): 1825-1844.10.1038/cdd.2017.12628937684MaiuriLRaiaVKroemerGStrategies for the etiological therapy of cystic fibrosisCell Death Differ2017241118251844Open DOISearch in Google Scholar
Noveski P, Madjunkova S, Mircevska M, Plaseski T, Filipovski V, Plaseska-Karanfilska D. SNaPshot assay for the detection of the most common CFTR mutations in infertile men. PloS One. 2014; 9(11): ell2498.NoveskiPMadjunkovaSMircevskaMPlaseskiTFilipovskiVPlaseska-KaranfilskaDSNaPshot assay for the detection of the most common CFTR mutations in infertile menPloS One2014911ell249810.1371/journal.pone.0112498Search in Google Scholar
Fustik S, Jakovska T, Plaseska-Karanfilska D. Hyponatremic dehydration and metabolic alkalosis as dominant manifestation in cystic fibrosis infants with mild phenotype – a case series. Srpski Arhiv za Celokupno Lekarstvo. 2018; 146(9-10): 581-583.10.2298/SARH170811053FFustikSJakovskaTPlaseska-KaranfilskaDHyponatremic dehydration and metabolic alkalosis as dominant manifestation in cystic fibrosis infants with mild phenotype – a case seriesSrpski Arhiv za Celokupno Lekarstvo20181469-10581583Open DOISearch in Google Scholar
Simova L, Williams C, Efremov GD, Gordova-Muratovska A, Sustic S, Watson EK, et al. δF508 frequency and associated haplotypes near the cystic fibrosis locus in the Yugoslav population. Hum Genet. 1990; 85(4): 432-433.10.1007/BF02428301SimovaLWilliamsCEfremovGDGordova-MuratovskaASusticSWatsonEKet alδF508 frequency and associated haplotypes near the cystic fibrosis locus in the Yugoslav populationHum Genet1990854432433Open DOISearch in Google Scholar
Petreska L, Koceva S, Plaseska D, Chernick M, Gordova-Muratovska A, Fustic S, et al. Molecular basis of cystic fibrosis in the Republic of Macedonia. Clin Genet. 1998; 54(3): 203-209.9788722PetreskaLKocevaSPlaseskaDChernickMGordova-MuratovskaAFusticSet alMolecular basis of cystic fibrosis in the Republic of MacedoniaClin Genet199854320320910.1111/j.1399-0004.1998.tb04285.xSearch in Google Scholar
Radivojevic D, Djurisic M, Lalic T, Guc-Scekic M, Savic J, Minic P, et al. Spectrum of cystic fibrosis mutations in Serbia and Montenegro and strategy for prenatal diagnosis. Genet Test. 2004; 8(3): 276-280.10.1089/gte.2004.8.27615727251RadivojevicDDjurisicMLalicTGuc-ScekicMSavicJMinicPet alSpectrum of cystic fibrosis mutations in Serbia and Montenegro and strategy for prenatal diagnosisGenet Test200483276280Open DOISearch in Google Scholar
Festini F, Taccetti G, Repetto T, Mannini C, Neri S, Bisogni S, et al. Incidence of cystic fibrosis in the Albanian population. Pediatr Pulmonol. 2008; 43(11): 1124-1129.10.1002/ppul.2092018972414FestiniFTaccettiGRepettoTManniniCNeriSBisogniSet alIncidence of cystic fibrosis in the Albanian populationPediatr Pulmonol2008431111241129Open DOISearch in Google Scholar
Kanavakis E, Efthymiadou A, Strofalis S, Doudounakis S, Traeger-Synodinos J, Tzetis M. Cystic fibrosis in Greece: Molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals. Clin Genet. 2003; 63(5): 400-409.10.1034/j.1399-0004.2003.00067.x12752573KanavakisEEfthymiadouAStrofalisSDoudounakisSTraeger-SynodinosJTzetisMCystic fibrosis in Greece: Molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individualsClin Genet2003635400409Open DOISearch in Google Scholar
Dobra R, Edmondson C, Hughes D, Martin I, Davies JC. Potentiators and correctors in paediatric cystic fibrosis patients: A narrative review. Paediatr Drugs. 2018; 20(6): 555-566.10.1007/s40272-018-0315-z30328089DobraREdmondsonCHughesDMartinIDaviesJCPotentiators and correctors in paediatric cystic fibrosis patients: A narrative reviewPaediatr Drugs2018206555566Open DOISearch in Google Scholar
